Morristown Medical Center Randomizes First Patient in World to New Study to Evaluate Treatment for Asymptomatic Severe Aortic Stenosis | Read More

Joint Commission Compendium of Resources is Now Available to the Public for Free | Read More

Bothell, WA, 22 May 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society International Conference in Washington, D.C. | Read More

Boston Scientific Corporation announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-fron | Read More

First U.S. Trial to Assess Delivery of a -Limus Agent to Prevent BTK Restenosis | Read More

BIOTRONIK’s Bare Metal Stent Proves Effective and Versatile as Standalone and in Combination with Drug-Coated Balloon in 12-Month Results of BIOFLEX PEACE and BIOLUX 4EVER   | Read More

PARIS - April 26, 2017—LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), a severe form of peripheral artery disease (PAD), announced today that the U.S. | Read More

DUBLIN and LONDON - April 25, 2017 - Medtronic plc (NYSE: MDT)  - News from Charing Cross. | Read More

New Medtronic Data Demonstrate Clinical and Quality of Life Benefits for VenaSeal Closure System in Venous Reflux Disease Patients | Read More